Richard Hague

2017 - Anika Therapeutics

In 2017, Richard Hague earned a total compensation of $1.1M as Chief Commerical Officer at Anika Therapeutics, a 17% decrease compared to previous year.

Compensation breakdown

Bonus$102,698
Option Awards$599,331
Salary$326,025
Other$27,096
Total$1,055,150

Hague received $599.3K in option awards, accounting for 57% of the total pay in 2017.

Hague also received $102.7K in bonus, $326K in salary and $27.1K in other compensation.

Rankings

In 2017, Richard Hague's compensation ranked 8,739th out of 14,666 executives tracked by ExecPay. In other words, Hague earned more than 40.4% of executives.

ClassificationRankingPercentile
All
8,739
out of 14,666
40th
Division
Manufacturing
3,330
out of 5,772
42nd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
433
out of 859
50th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
241
out of 531
55th
Industry
Surgical and Medical Instruments and Apparatus
148
out of 336
56th
Source: SEC filing on April 17, 2018.

Hague's colleagues

We found six more compensation records of executives who worked with Richard Hague at Anika Therapeutics in 2017.

2017

Charles Sherwood

Anika Therapeutics

Chief Executive Officer

2017

Joseph Darling

Anika Therapeutics

President

2017

Sylvia Cheung

Anika Therapeutics

Chief Financial Officer

2017

Edward Ahn

Anika Therapeutics

Chief Technology and Strategy Officer

2017

Ed Ahn

Anika Therapeutics

Chief Technology and Strategy Officer

2017

Thomas Finnerty

Anika Therapeutics

Chief Human Resources Officer

News

In-depth

You may also like